#10054 on the rich list of 14,452 insiders
John A. Stalfort III
Director at Taysha Gene Therapies; Director at Verrica Pharmaceuticals; Director at Acumen Pharmaceuticals. Based in Newton, Massachusetts.
$8.4M
in disclosed stock, −$448K (−5.09%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 10054th of 14,452
- Companies held
- 3
- Largest holding
- TSHA, 93.0% of total
- Latest SEC filing
- Jun 3, 2026
What the $8.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Taysha Gene Therapies TSHA Common Stock | Directly | 1,176,559 | $3.77 | $4.4M | 53.1% | Form 4, Jun 1, 2026 |
| Taysha Gene Therapies TSHA Common Stock | Through John A. Stalfort III 2018 Irrevocable Trust | 884,290 | $3.77 | $3.3M | 39.9% | Form 4, Jun 1, 2026 |
| Verrica Pharmaceuticals VRCA Common Stock | Directly | 187,380 split-adjusted | $2.89 | $541K | 6.5% | Form 4, Nov 26, 2024 |
| Acumen Pharmaceuticals ABOS Common Stock | Directly | 220,624 | $0.19 | $43K | 0.5% | Form 4, Jun 3, 2026 |
Share counts are the amounts John A. Stalfort III reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 10051 | Sundeep Agrawal Director, BlossomHill Therapeutics. San Diego, CA | $8.4M |
| 10052 | Stephen J. Hagge Director, CF Industries Holdings. Tampa, FL | $8.4M |
| 10053 | Russell Wayne Ford Chief Executive Officer, StandardAero. Scottsdale, AZ | $8.4M |
| 10054 | John A. Stalfort III Director, Taysha Gene Therapies. Newton, MA | $8.4M |
| 10055 | Tony Kim Insider, BlackRock Science and Technology Term Trust. New York, NY | $8.4M |
| 10056 | Andrew Joseph Bestwick CHIEF TECHNOLOGY OFFICER, Rigetti Computing. Berkeley, CA | $8.4M |
| 10057 | John T. Raymond Director, Plains GP Holdings. Houston, TX | $8.4M |
Other Taysha Gene Therapies insiders
All TSHA insiders- Paul B. Manning$86.4M10% owner. #663 overall
- R.A. Session II$34.0M10% owner. #3424 overall
- Sean P. Nolan$16.8MChief Executive Officer. #5403 overall
- Kamran Alam$5.4MCHIEF FINANCIAL OFFICER. #13657 overall
Questions
How much stock does John A. Stalfort III own?
John A. Stalfort III holds $8,352,639 in listed stock based on SEC filings and current prices, mostly Taysha Gene Therapies (TSHA). That ranks 10054th on the Stock Rich List.
Is this John A. Stalfort III's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.